CARVILIN 12.5 / 6.25 TAB

CARVILIN 12.5 / 6.25 TAB (Carvedilol 12.5 mg / 6.25 mg Tablets)

For Regaining heart health

Carvedilol

Beta) adrenoreceptor blocking activity.

  • Percent in S (-) enantiomer 
  • Suppresses reninangiotensin through non-Selective Beta -blokade

a1-adrenergic blocking activity

  • present in R(+) and S (-) enantiomers at equal potency 
  • Reduces the peripheral vascular resistance

INDICATION

  • For mild-to- severe chronic heart failure of ischemic or cardiomyopathic  origin (Usually in addition to diuretics, ACE inhibitors, and Digitalis)
  • In left Ventricular dysfunction following myocardial infarction
  • For the management of essential hypertension (as alone or in combination with other anti hypertensive agents, especially thiazide -type diuretics)

Dosage

  • Heart failure - 3.215 mg Twice daily for 2 weeks 
  • Hypertension - 6.25 mg Twice daily 
  • Left Ventricular dysfunction following myocardial infarction 6.25mg Twice daily